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Abstract 
Hepatitis remains major public health problem in the country, also one of the leading causes of death. The present work was 
conducted to define the incidence of HBV and HCV infections and related risk factors among young orphan students from different 
areas of District Swat. A total of 175 samples within the age group of 5-17 years were studied of which 109 were males and 66 
females. Initially, samples were examined by immunochromatographic assay (ICT) and were further analyzed by PCR method. 
61(34.85%) subjects were found positive for HCV by ICT strip and 31 of these were confirmed by PCR, having 20 male and 11 
female. The prevalence rate was recorded 17.71 % for HCV in selected areas. Similarly, for HBV a total of 7 (4%) patients were 
recorded positive by ICT and 3 (2.75 %) male subject were confirmed by PCR. No female subject was found HBV positive. Total 
HBV prevalence rate was 1.71 %. Disease frequency revealed increasing configuration and massive health education campaign is 
needed in related areas of Swat regarding hepatitis B and C viral infections. Vaccination at all health care channels should be 
planned to limit its spread. 
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INTRODUCTION 
Globally hepatitis is one of the leading causes of death 
and spread via contaminated blood and related products. 
The World Health Organization (WHO) recorded 780,000 
deaths with chronic hepatitis B virus infection per year and 
240 million infected people worldwide (Harris et al., 2017; 
Kalim et al., 2017). It was also reported that about 3-4 million 
people are infected each year via hepatitis C virus among 
180 million infected people (Khan and Murad, 2015; Kalim et 
al., 2017). Theses chronic infections lead to hepatocellular 
carcinoma (HCC), hematologic diseases, hepatic and renal 
disorders, and cirrhosis (Ali et al., 2015; Cacoub et al., 2017). 
Number of studies also reported thyroid dysfunction after 
interferon treatments (Tomer et al., 2007; Andrade et al., 
2011). Lead acetate changes the serum AST and ALT levels 
by affecting the liver (Khanam et al., 2016). Elevation of liver 
enzymes is responsible for liver disorders (Toor et al., 2016). 
It was reported that incidence of HCV and HBV infections in 
Pakistan is 5% and 4.8% respectively and these are the 
leading cause of hepatocellular carcinoma (Ali et al., 2011; 
Imran et al., 2014). Another study reported the prevalence 
rate of Hepatitis C (HCV) in Pakistan from 4.5% to 8% (about 
10 million people) (Irfan et al., 2016). HCC cases (87%) are 
due to these infections in which HBV contributed 22% and 
HCV 68% (Parkash and Hamid, 2016). 
Transmission route of HBV and HCV is mainly through 
exposure to contaminated blood and blood products like 
sharing syringes and needles (93%), sexual contacts with 
infected victim (82%) and alcohol intake (61%) in different 
regions of Pakistan (Mansha et al., 2017). Vertical 
transmission was reported the most prominent one among 
young individuals for HCV (Benova et al., 2014; Cottrell et 
al., 2013). The risk of vertical transmission in Pakistan was 
recorded low at ˂0.1%. However, the estimated infection of 
HCV was lesser than past record (Gower et al., 2014). The 
infection rate of HBV in Pakistan is 2-4% defining Pakistan 
as an intermediate source of infection (Harris et al., 2017). 
Overall genotype study of HBV in Pakistan indicated 63.7% 
predominant exposure for genotype D, followed by B 
(26.7%), and genotype A (4.9%) (Alam et al., 2007; Ali et al., 
2011; Mahmood et al., 2016). 
Enormous contribution occurs globally in health 
extortions due to hepatitis B and C infections, especially in 
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developing countries where public awareness is limited 
(Lavanchy, 2009; Rantala and van de Laar, 2008). Several 
studies were carried out in Pakistan to demonstrate the 
distribution of HBV and HCV in general population with 
associated risk factors (Ali et al., 2009; Khan et al., 2003). 
The aim of this study was to estimate the incidence of HCV 
and HBV infections in young orphan students of District 
Swat. The specificity and sensitivity of ICT and PCR 
techniques were elevated to determine the ratios. This study 
is important due to targeted urban areas and orphan 
students considerations. 
                                                        
MATERIALS AND METHODS 
Sample screening 
Volunteer young orphan students of 5 to 17 years age, 
were studied from different areas of District Swat. Blood 
samples were collected by using sterile 5ml syringe under 
strict sterile conditions. The isolated samples were 
transferred to laboratory and processed to collect the serum 
and further to screen out the hepatitis B and C by using 
screening kits (ICT: ACON, ACON Laboratories Inc., San 
Diego, CA 92121, USA) (Kalim et al., 2017). 
 
PCR confirmation of HCV 
Blood samples were processed for isolation of plasma 
and further analyzed for total RNA isolation using TRIZOL-
REAGENT kit (INVITROGEN) following the manufacture 
standard protocol. The complementary DNA products were 
obtained by using RT-PCR analysis tools via reverse 
polymerases (M-MuLV-Moloney Murine Leukemia Virus) 
and further analyzed for PCR amplification. The product was 
amplified in two different rounds. In first round two primers 
were used as forward and reverse having nucleotide 
sequence of CCCTGTGNNNNNNCTGTCTTCACGC and 
ACTCGCAAGCNNNNNAGGCAGTAC. In second round of 
PCR the following forward and reverse primers were used to 
polymerize the targeted internal region to confirm the 
presence of HCV: GAAAGCGTNNNNNTGGCG and 
CACAAGGNNNNNCGACC-3’. 1% agarose gel was used for 
loading the sample and bands were observed under UV 
light. 
 
PCR confirmation of HBV 
ICT positive samples were further analyzed to isolate 
DNA by using DNAzol
® 
BD following the procedure 
described by the manufacturer. These DNA samples were 
amplified twice in two different rounds. The following forward 
and reverse primers were used in first round amplification: 
(5’-CATCCTGCTGNNNNCCTCATCT-3’ and 5’-
CGAACCACTNNNNATGGCACT-3’). The first round product 
was used as template for the nested PCR based 
amplification using the following primers: (5’-
GGTATGTTGNNNNTGTCCTCT-3’ and 5’-
GGCACTAGNNNNNGAGCCA-3’). The second round 
polymerization targets the inner regions of the DNA fragment 
amplified in the first PCR reaction.  1% agarose gel was 
used for analysis.  
 
Statistical analysis 
The data obtained was analyzed using computer 
software SPSS (IBM Inc.) and results were tabulated. 
 
RESULTS  
Considering the total population size screened for 
hepatitis, samples were initially tested by using ICT analysis 
and 61 (34.85%) were calculated positive for HCV antibodies 
test. Out of these, 42 (68.85%) male samples were recorded 
positive and 19 (31.14%) samples of female students were 
positive (Table 1). To confirm these positive samples were 
further subjected to PCR analysis (Figure 1) to make sure 
the positive clones for hepatitis C related RNA and found 
that 31 individuals (71.71%) were confirmed positive for 
hepatitis C in the serum. The prevalence ratio was 
conducted and 20 (18.34%) individuals were males and 11 
(16.67%) were recorded females. 38.53% individuals among 
male students with total percentile incidence of 18.34% as 
shown in Table 2. By ICT analysis, 28.78% were found 
positive for hepatitis C viral antibodies detection and later on 
analyzed by using PCR detection including 16.67% was set 
positive for HCV. The HCV prevalence was recorded 
17.71% in young orphans of District Swat which is alarming 
for all health professionals. 
 
Table 1. Hepatitis positive patients among total 
screened samples 
Sample Male Female HBV (+) HCV (+) 
175 109 66 7 (4%) 61 (34.8%) 
 
 
Table 2. Gender wise prevalence of HCV 
M/F Samples ICT (+) PCR (+) 
Male 109 42 (38.5%) 20 (18.34%) 
Female 66 19(28.78%) 11 (16.67%) 
Total 175 61 (34.85%) 31 (17.71%) 
 
 
Incidence of hepatitis B in total population size 
screened was recorded less than HCV. Total samples were 
initially screened via ICT test and only 7 (4.0%) individual 
were found positive for hepatitis B virus. These positive 
samples were comprised of 6 male students and only one 
female individual. By confirmation with polymerase chain 
reaction (Figure 2), we found three male individuals 
confirmed positive with prevalence ratio of 2.75% and no 
confirmed results were recorded for female students. 
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Fig. 1. Detection of HCV through PCR. 2% agarose gel 
was used for it.  
Lane M indicates 1kb plus 100bp DNA ladder marker vol. 
250 µl (83 µg) cat# EMB 1003C: Lanes 1-4, 6, 8 show 
positive results of HCV; Lanes 5, 7, 9 are negative for HCV. 
 
 
 
 
 
Fig. 2. PCR confirmation of HBV.  
Lanes 2-5 show positive results; lane M indicate molecular 
marker. 1% agarose gel was used for differentiation 
 
The one individual was counted as false positive in 
initial screening (Table 3). The resulted final prevalence rate 
for HBV was recoded 1.71% among all tested samples. 
 
Table 3. Gender wise prevalence of HBV 
M/F Total ICT (+) PCR (+) 
Male 109 6 (5.5%) 3 (2.75%) 
Female 66 1 (1.51%) 0 (0%) 
Total 175 7 (4%) 3 (1.71%) 
 
DISCUSSION  
District Swat of Malakand is located in Khyber 
Pakhtunkhwa with total population of 1257602 (according to 
1998 censuses, Directorate of Information Technology, 
Government of KP). Our study of prevalence and incidence 
of HBV and HCV infections was focused on young orphan 
students of different age groups. All these tested individuals 
belong to rural areas of Swat where the chances of rapid 
growth of hepatitis are prominent due to lack of proper 
treatment and hepatitis awareness and precautions. In 
studied individuals 4.0% were found to have antibodies in 
their blood against HBV and 34.85% against HCV related 
viruses. It was reported that HCV prevalence in Swat is 
13.8% with positivity of 4.7% (Ahmad et al., 2009). In 
another study, 30 (10.71%) patients were positive for Anti 
HCV, 27 (9.64%) for HBs Ag and no record were found in 
individuals having both conditions (Kalim et al., 2017). The 
PCR analysis proved only 1.71% prevalence rate for HBV 
and 17.71% for HCV from the blood serum. 
It was also reported that none of the screened sample 
hold both hepatitis B and C co-infections. Baig et al. (2009) 
reported highest frequency of super infection of hepatitis C 
and D in HBV cirrhosis patients in Pakistan. A previous study 
reported the prevalence rate of HBV was 0.96% and that of 
HCV was 7.5% in studied population whose age ranges from 
7 years to 70 years (Rauf et al., 2013). Some results of this 
research do not match with the existing results of different 
areas of Pakistan. In our study the prevalence of HBV was 
1.71% and that of HCV was 17.71%. The results of another 
study are quite different to current work as reported by 
Sarwar and co-workers from different area of Abbotabad 
region (Sarwar et al., 2008). They found co infection of both 
HBV and HCV which was recorded 40% as in our work there 
was no co infection recorded. The reported study also 
coincides with our prevalence analysis that showed higher 
recorded prevalence rates in male individual as compared to 
females (Muhammad and Jan, 2005). Similarly the 
percentage of co-infection HBV with diabetes was reported 
to be 12.80% (Muhammad et al., 2013). In another study 
rate of HBV infection was 25% among male malarial patients 
while in females rate was 23% (Dilshad et al., 2016). 
 
CONCLUSION AND RECOMMENDATIONS 
Pakistan is being considered as high prevalence and 
risk related country of hepatitis infections. The frequency 
distribution of HBV and HCV showed an alarming pattern of 
threats that acquires a special attention. Both electronic and 
printing media related health education campaigns are 
needed in rural areas of Pakistan with hepatitis and co-
infection. Proper arrangement of vaccination must be 
required and abundance of contaminated needles and blood 
transfusion ailments need to be eliminated to eradicate 
hepatitis. The most prominent weapon for hepatitis spread 
was found the recycling of these sources in different health 
workplaces. The local medical staffs must be proper trained 
and well equipped to deliver the proper treatments and also 
aware the victim against the threats. As in rural areas the 
surgical tools are not properly sterilized and freely used 
careless of infection so these must be eliminated. At last but 
not the least, to avoid use of unsafe blood and blood product 
transfusion, share blades, and unsterilized instruments in 
barber shops. It is suggested that all the patients who need 
surgery or any other treatments from doctors they should be 
properly screened for HBV and HCV. It is also necessary 
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that separate operation theaters and instruments should be 
used for HBV and HCV positive cases. Tremendous efforts 
are needed in the form of print and electronic media to 
achieve reduction of these infections especially HCV and 
HBV. 
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